TREM2 anticorps (Middle Region)

N° du produit ABIN633058

Détail du produit anti-TREM2 anticorps

Antigène: TREM2 (Triggering Receptor Expressed On Myeloid Cells 2 (TREM2))

Épitope: Middle Region

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TREM2 est non-conjugé

Application: Western Blotting (WB)

Specificité: TREM2 antibody was raised against the middle region of TREM2

Purification: Affinity purified

Immunogène: TREM2 antibody was raised using the middle region of TREM2 corresponding to a region with amino acids FPGESESFEDAHVEHSISRSLLEGEIPFPPTSILLLLACIFLIKILAASA

Information d'application

Indications d'application: WB: 1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

TREM2 Blocking Peptide, catalog no. 33R-3016, is also available for use as a blocking control in assays to test for specificity of this TREM2 antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of TREM2 antibody in PBS

Concentration: Lot specific

Buffer: PBS

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Détails sur TREM2

Antigène: TREM2 (Triggering Receptor Expressed On Myeloid Cells 2 (TREM2))

Autre désignation: TREM2 (TREM2 Produits)

Synonymes: anticorps TREM-A1, anticorps TREM-B1, anticorps TREM2, anticorps trem-2, anticorps trem2a, anticorps trem2b, anticorps trem2c, anticorps TREM-2, anticorps Trem2a, anticorps Trem2b, anticorps Trem2c, anticorps triggering receptor expressed on myeloid cells 2, anticorps trem-like transcript 2 protein, anticorps TREM2, anticorps trem2, anticorps LOC100228399, anticorps Trem2

Sujet: The protein encoded by this gene is a membrane protein that forms a receptor signaling complex with TYROBP. The encoded protein may be involved in chronic inflammation by triggering the production of constitutive inflammatory cytokines. Defects in this gene are a cause of polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL).

Poids moléculaire: 25 kDa (MW of target protein)